Trials / Unknown
UnknownNCT04811326
Latanoprost Plus NB-UVB Versus Each Alone in Non-segmental Vitiligo: Clinical and Laboratory Evaluation
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 150 (estimated)
- Sponsor
- Shaimaa Fawzy Abdel-rady Abdel-latif · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Accepted
Summary
The aim of the study is to evaluate the efficacy of different lines of therapies on the TWEAK serum level in patients with non-segmental vitiligo.
Detailed description
the study is to evaluate the efficacy of NB-UVB, latanoprost, and combination of them on the TWEAK serum level in patients with non-segmental vitiligo.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | NB-UVB | radiation |
| DRUG | Latanoprost | eye drops |
Timeline
- Start date
- 2021-01-13
- Primary completion
- 2024-02-13
- Completion
- 2024-03-13
- First posted
- 2021-03-23
- Last updated
- 2023-08-09
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT04811326. Inclusion in this directory is not an endorsement.